Ety Guidelines and Issues in Cancer Screening. CA Cancer J Clin 2010, 60(2):99?19. 2. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA Cancer J Clin 2013, 63(1):11?0. 3. Feinberg AP, Tycko B: The history of cancer epigenetics. Nat Rev Cancer 2004, 4(2):143?53. 4. Kim MY, Hur J, Jeong S: Emerging roles of RNA and RNA-binding protein network in cancer cells. BMB Rep 2009, 42(3):125?30. 5. Krecic AM, Swanson MS: hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol 1999, 11(3):363?71. 6. Dreyfuss G, Matunis MJ, Pinol-Roma S, Burd CG: hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem 1993, 62:289?21. 7. Audic Y, Hartley RS: Post-transcriptional regulation in cancer. Biol Cell 2004, 96(7):479?98. 8. Yisraeli JK: VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins. Biol Cell 2005, 97(1):87? HJ, Watford W, Li CL, Parmelee A, Bryant MA, Deng CX, O’Shea J, Lee SB: Ewing sarcoma gene EWS is essential for meiosis and B lymphocyte development. J Clin Invest 2007, 117(5):1314?323. Sonenberg N, Hinnebusch AG: New modes of translational control in development, behavior, and disease. Mol Cell 2007, 28(5):721?29. Shu L, Yan W, Chen X: RNPC1, an RNA-binding protein and a target of the p53 family, is required for maintaining the stability of the basal and stress-induced p21 transcript. Genes Dev 2006, 20(21):2961?972. Yan W, Zhang J, Zhang Y, Jung YS, Chen X: p73 expression is regulated by RNPC1, a target of the p53 family, via mRNA stability. Mol Cell Biol 2012, 32(13):2336?348. Cho SJ, Zhang J, Chen X: RNPC1 modulates the RNA-binding activity of, and cooperates with, HuR to regulate p21 mRNA stability. Nucleic Acids Res 2010, 38(7):2256?267. Yin T, Cho SJ, Chen X: RNPC1, an RNA-binding protein and a p53 target, regulates macrophage inhibitory cytokine-1 (MIC-1) expression through mRNA stability. J Biol Chem 2013, 288(33):23680?3686. Zhang J, Jun Cho S, Chen X: RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability. Proc Natl Acad Sci U S A 2010, 107(21):9614?619. Xu E, Zhang J, Chen X: MDM2 expression is repressed by the RNA-binding PubMed ID: protein RNPC1 via mRNA stability. Oncogene 2013, 32(17):2169?178. Zhang J, Cho SJ, Shu L, Yan W, Guerrero T, Kent M, Skorupski K, Chen H, Chen X: Translational repression of p53 by RNPC1, a p53 target overexpressed in Relugolix solubility lymphomas. Genes Dev 2011, 25(14):1528?543. Miyamoto S, Hidaka K, Jin D, Morisaki T: RNA-binding proteins Rbm38 and Rbm24 regulate myogenic differentiation via p21-dependent and -independent regulatory pathways. Genes Cells 2009, 14(11):1241?252. Zheng SL, Xu JF, Isaacs SD, Wiley K, Chang BL, Bleecker ER, Walsh PC, Trent JM, Meyers DA, Isaacs WB: Evidence for a prostate cancer linkage to chromosome 20 in 159 hereditary prostate cancer families. Hum Genet 2001, 108(5):430?35. Bar-Shira A, Pinthus JH, Rozovsky U, Goldstein M, Sellers WR, Yaron Y, Eshhar Z, Orr-Urtreger A: Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Cancer Res 2002, 62(23):6803?807. Tanner MM, Grenman S, Koul A, Johannsson O, Meltzer P, Pejovic T, Borg A, Isola JJ: Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Genes Cells 2000, 6(5):1833?839. Korn WM, Yasutake T, Kuo WL, Warren RS, Collins C, Tomita M, Gray J, Waldman FM: Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastati.